Pfizer’s Double Dose Of Good News: Caduet Combo, Spiriva Clear FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Caduet clears FDA for the "simultaneous treatment of high blood pressure and high cholesterol," Pfizer says. The Norvasc and Lipitor combination product could broaden Pfizer’s reach in the cholesterol market.